http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49c7411b461c2047c15e3ddf0f29ea4f
Outgoing Links
Predicate | Object |
---|---|
family-name | Settleman |
name | Jeffrey Settleman |
given-name | Jeffrey |
organization-name | MGH Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, Massachusetts 02129 Authors' Affiliation: Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 1Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts; Discovery Oncology, Genentech, South San Francisco, CA 94080; Massachusetts General Hospital Cancer Center and Harvard Medical School, Building 149, 13th Street, Charlestown, MA 02129; and ONYX Pharmaceuticals, Inc., Richmond, CA, 94806 Genentech, South San Francisco, CA 94080, USA Genentech Inc., South San Francisco, CA 94080, USA. Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA. Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129 Authors' Affiliations: Departments of 1Pathology, 2Surgery, and 3Dermatology, Massachusetts General Hospital; 4Massachusetts General Hospital Cancer Center; and 5Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: Departments of 1Pathology, 2Surgery, and 3Dermatology, Massachusetts General Hospital; 4Massachusetts General Hospital Cancer Center; and 5Harvard Medical School, Boston, Massachusetts *Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, MA 02129; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129 Massachusetts General Hospital Cancer Center and Harvard Medical School (J.S.), Charlestown, Massachusetts 02129 Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Building 149, 13th Street, Charlestown, MA 02129, USA. Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, 2Department of Medicine, Harvard Medical School, 3Division of Gastro-enterology, Tufts Medical Center, and Departments of 4Pathology and 5Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and 6Genentech, Inc., South San Francisco, California From the Massachusetts General Hospital Cancer Center; Departments of Pathology and of Radiology, Massachusetts General Hospital; Hematology/Oncology Division, Beth Israel Deaconess Medical Center; and Department of Pathology, Brigham and Women's Hospital, Boston, MA; and Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts Department of Human Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510-8005 5Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 2Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129 ‡Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129; and Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston; and Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, Massachusetts 02129 Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown Authors' Affiliations: 1Massachusetts General Hospital Cancer Center; 2Department of Medicine, Harvard Medical School; and 3Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 4Division of General and Laparoscopic Surgery, European Institute of Oncology and University of Milan, Milan, Italy; and 5Department of Pathology and New York University Cancer Institute, New York University School of Medicine, New York, New York; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center; 2Department of Medicine, Harvard Medical School; and 3Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 4Division of General and Laparoscopic Surgery, European Institute of Oncology and University of Milan, Milan, Italy; and 5Department of Pathology and New York University Cancer Institute, New York University School of Medicine, New York, New York Authors' Affiliations: Departments of 1Discovery Oncology, 2Molecular Biology, 3Bioinformatics, 4Pathology, and 5Molecular Oncology, Genentech Inc., South San Francisco, California Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, U.S.A.; Discovery Oncology, Genentech, South San Francisco, CA 94080, U.S.A. 1Division of Hematology/Oncology, Massachusetts General Hospital; From the Massachusetts General Hospital Cancer Center; Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital; Department of Pathology, Massachusetts General Hospital; Department of Biostatistics, Massachusetts General Hospital, Boston; Harvard Medical School/Partners Health Care Center for Genetics and Genomics, Cambridge, MA; University of Washington, Seattle, WA; Sarah Cannon Research Institute, Nashville, TN; Fletcher Allen Health Care, Burlington, VT; Fairfax-Northern... 1Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts and *Massachusetts General Hospital Cancer Center,; Harvard Medical School, Charlestown, MA 02129; and Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129 Authors' Affiliations: 1Massachusetts General Hospital Cancer Center and 2Center for Molecular Therapeutics, Harvard Medical School, Charlestown, Massachusetts; 3Howard Hughes Medical Institute, 4Center for Head and Neck Cancers, 5Department of Pathology, and 6Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 7Biotheranostics, San Diego, California; and Departments of 8Pathology and 9Medicine, University of Chicago, Chicago, Illinois; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center and 2Center for Molecular Therapeutics, Harvard Medical School, Charlestown, Massachusetts; 3Howard Hughes Medical Institute, 4Center for Head and Neck Cancers, 5Department of Pathology, and 6Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 7Biotheranostics, San Diego, California; and Departments of 8Pathology and 9Medicine, University of Chicago, Chicago, Illinois Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129; Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115 Authors' Affiliations: 1Genentech, Inc., South San Francisco, California; and 2Argenta Discovery Ltd., Harlow, Essex, United Kingdom Department of Physiology, Semmelweis University, P.O. Box 259, H-1444 Budapest, Hungary, Laboratoire DBMS/BBSI, CEA Grenoble, 17 Rue des Martyrs, 38054 Grenoble Cedex 9, France, and Massachusetts General Hospital Cancer Center and Harvard Medical School, Building 149, 13th Street, Charlestown, Massachusetts 03125 Authors' Affiliations: 1Laboratory of Cellular & Molecular Radiation Oncology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Charlestown; 2Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; and 3Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts; 4Research Oncology, Genentech, Inc., South San Francisco, California; 5Department of Pharmaceutical Biology, Ludwig Maximilian University of Munich, Munich; and 6Center for Oncology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany; Authors' Affiliations: 1Laboratory of Cellular & Molecular Radiation Oncology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Charlestown; 2Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; and 3Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts; 4Research Oncology, Genentech, Inc., South San Francisco, California; 5Department of Pharmaceutical Biology, Ludwig Maximilian University of Munich, Munich; and 6Center for Oncology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany Discovery Oncology, Genentech, Inc., South San Francisco, CA 94080 1Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts and Massachusetts General Hospital, Harvard Medical School Authors' Affiliations: Departments of 1Discovery Oncology, 2Molecular Biology, 3Research Oncology, and 4Bioinformatics, Genentech Inc., South San Francisco, California Center for Molecular Therapeutics and Medical Oncology Unit, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129; and Departments of Oncology Research and Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965 Massachusetts General Hospital Cancer Center and Harvard Medical School , Charlestown, Massachusetts 02129 Authors' Affiliations: 1Laboratory of Cellular & Molecular Radiation Oncology and 2Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts; 3Department of Radiation Oncology, University of Hamburg, Hamburg, Germany; 4Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts; and 5Department of Radiation Oncology, University Hospital Carl Gustav Carus, Dresden, Germany 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts and 1 Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA *Cancer Center and |
Incoming Links
Total number of triples: 184.